14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
IHF vs IAK: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, iShares U.S. Healthcare Providers ETF (IHF) is the stronger overall head-to-head candidate over iShares U.S. Insurance ETF (IAK) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). IHF carries a Unified Composite Score of 47.8/100 (HOLD) at $60.79 (N/M Forward P/E, N/A operating margin), whereas IAK carries 39.9/100 (SELL) at $153.39 (N/M Forward P/E, N/A operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IHF vs IAK. Trailing 12-month operating profitability (IHF N/A vs IAK N/A) and valuation multiples (IHF N/M vs IAK N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ IHF vs IAK Key Questions & Quantitative Answers
As of Nov 16, 2026, iShares U.S. Healthcare Providers ETF (IHF) is the stronger overall head-to-head candidate over iShares U.S. Insurance ETF (IAK) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). IHF carries a Unified Composite Score of 47.8/100 (HOLD) at $60.79 (N/M Forward P/E, N/A operating margin), whereas IAK carries 39.9/100 (SELL) at $153.39 (N/M Forward P/E, N/A operating margin). Technically, IHF sits in a Markup phase (RSI 60.9, UNCLASSIFIED options structure) and IAK sits in a Markup phase (RSI 64.3, UNCLASSIFIED options structure).
IHF and IAK split Growth & Scale metrics: IHF posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with IAK at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, IHF generates N/A in USD-normalized revenue versus N/A for IAK. In operating R&D and SG&A reinvestment, IHF deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for IAK.
IHF and IAK trade at balanced relative valuation multiples. IHF trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas IAK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IHF (N/A ROE) versus IAK (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, IHF carries 18.0% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.30β · 18% Vol realized risk). By comparison, IAK carries 15.8% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.07β · 20% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.